Variable | Coefficient | 95% CI | P values | Tau2 |
Unadjusted | ||||
No covariate | 451.1 | |||
Year of publication | 6.39 | −1.24 to 14.02 | 0.10 | 232.7 |
Duration of follow-up | −0.82 | −1.86 to 0.22 | 0.12 | 185.3 |
Vitamin K form | 23.64 | −13.33 to 60.60 | 0.21 | 278.0 |
Dose | −0.01 | −0.04 to 0.02 | 0.42 | 366.1 |
Adjusted | ||||
Model 1 | ||||
Duration of follow-up | −0.82 | −1.58 to 0.05 | 0.04 | 66.7 |
Vitamin K form | 19.72 | −6.97 to 46.42 | 0.15 | |
Model 2 | ||||
Duration of follow-up | −1.03 | −1.45 to 0.61 | <0.001 | 0.0 |
Dose | −0.02 | −0.04 to 0.00 | 0.045 | |
Model 3 | ||||
Duration of follow-up | −0.51 | −1.67 to 0.65 | 0.39 | 195.1 |
Year of publication | 5.01 | −2.99 to 13.00 | 0.22 | |
Model 4 | ||||
Duration of follow-up | −0.70 | −2.23 to 0.83 | 0.37 | 339.5 |
Dose | −0.01 | −0.06 to 0.04 | 0.68 | |
Vitamin K form | 6.74 | −62.58 to 76.05 | 0.85 | |
Model 5 | ||||
Duration of follow-up | −0.81 | −1.31 to 0.31 | 0.002 | 0.74 |
Dose | −0.02 | −0.04 to 0.001 | 0.04 | |
Year of publication | 4.60 | −0.93 to 10.13 | 0.10 |